2023 Q2 Form 10-Q Financial Statement

#000090910823000036 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $33.35M $33.99M
YoY Change -14.53% -19.56%
Cost Of Revenue $823.1K $782.9K
YoY Change -1.72% -4.27%
Gross Profit $32.53M $33.21M
YoY Change -14.81% -19.86%
Gross Profit Margin 97.53% 97.7%
Selling, General & Admin $5.359M $5.159M
YoY Change -0.76% 5.34%
% of Gross Profit 16.48% 15.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $327.0K $328.0K
YoY Change -7.29% -9.63%
% of Gross Profit 1.01% 0.99%
Operating Expenses $25.56M $23.05M
YoY Change 36.2% -0.58%
Operating Profit $7.786M $10.94M
YoY Change -61.55% -42.63%
Interest Expense $6.361M $8.083M
YoY Change -136.1% -207.21%
% of Operating Profit 81.69% 73.87%
Other Income/Expense, Net $6.277M $8.083M
YoY Change -10800.15% -15341.82%
Pretax Income $14.06M $19.02M
YoY Change 446.42% 65.71%
Income Tax $3.894M $4.921M
% Of Pretax Income 27.69% 25.87%
Net Earnings $9.432M $12.71M
YoY Change 113.75% 39.19%
Net Earnings / Revenue 28.28% 37.39%
Basic Earnings Per Share $3.18 $4.20
Diluted Earnings Per Share $3.18 $4.20
COMMON SHARES
Basic Shares Outstanding 2.970M shares 3.053M shares
Diluted Shares Outstanding 2.970M shares 3.025M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.66M $40.33M
YoY Change -33.92% -31.38%
Cash & Equivalents $38.66M $40.33M
Short-Term Investments
Other Short-Term Assets $3.050M $3.431M
YoY Change -1.71% 8.64%
Inventory
Prepaid Expenses
Receivables $18.96M $18.84M
Other Receivables $0.00 $0.00
Total Short-Term Assets $60.67M $62.60M
YoY Change -24.93% -24.64%
LONG-TERM ASSETS
Property, Plant & Equipment $3.472M $3.913M
YoY Change -32.86% -30.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $27.67M $25.51M
YoY Change 146.19% 94.4%
Other Assets $12.55M $13.23M
YoY Change -5.86% 23.39%
Total Long-Term Assets $180.0M $171.9M
YoY Change 5.01% -3.57%
TOTAL ASSETS
Total Short-Term Assets $60.67M $62.60M
Total Long-Term Assets $180.0M $171.9M
Total Assets $240.6M $234.5M
YoY Change -4.59% -10.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.326M $7.156M
YoY Change -42.13% -10.16%
Accrued Expenses $14.39M $7.268M
YoY Change -22.42% -35.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.72M $16.72M
YoY Change -29.72% -30.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $33.21M $31.23M
YoY Change 13.44% -8.06%
Total Long-Term Liabilities $33.21M $31.23M
YoY Change 13.44% -8.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.72M $16.72M
Total Long-Term Liabilities $33.21M $31.23M
Total Liabilities $53.93M $47.95M
YoY Change -8.21% -17.35%
SHAREHOLDERS EQUITY
Retained Earnings $142.1M $137.1M
YoY Change 15.29% 10.97%
Common Stock $42.90M $55.69M
YoY Change -39.66% -33.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $163.9M $169.2M
YoY Change
Total Liabilities & Shareholders Equity $240.6M $234.5M
YoY Change -4.59% -10.27%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $9.432M $12.71M
YoY Change 113.75% 39.19%
Depreciation, Depletion And Amortization $327.0K $328.0K
YoY Change -7.29% -9.63%
Cash From Operating Activities $11.89M -$13.78M
YoY Change -15.9% 0.75%
INVESTING ACTIVITIES
Capital Expenditures $7.830K $13.88K
YoY Change -39.44%
Acquisitions
YoY Change
Other Investing Activities -$529.9K -$872.7K
YoY Change 47.87% -146.99%
Cash From Investing Activities -$537.8K -$886.6K
YoY Change 50.06% -148.34%
FINANCING ACTIVITIES
Cash Dividend Paid $4.576M
YoY Change -5.02%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.03M -$8.193M
YoY Change -7.3% -17.46%
NET CHANGE
Cash From Operating Activities 11.89M -$13.78M
Cash From Investing Activities -537.8K -$886.6K
Cash From Financing Activities -13.03M -$8.193M
Net Change In Cash -1.678M -$22.86M
YoY Change 506.21% 5.0%
FREE CASH FLOW
Cash From Operating Activities $11.89M -$13.78M
Capital Expenditures $7.830K $13.88K
Free Cash Flow $11.89M -$13.79M
YoY Change -15.96% 0.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000909108
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-24498
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
DIAMOND HILL INVESTMENT GROUP, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0190407
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
325 John H. McConnell Blvd., Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43215
CY2023Q1 dei City Area Code
CityAreaCode
614
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
255-3333
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2023Q1 dei Trading Symbol
TradingSymbol
DHIL
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2970475 shares
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
40334923 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
63195302 usd
CY2023Q1 us-gaap Investments
Investments
154784963 usd
CY2022Q4 us-gaap Investments
Investments
145675711 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
18835657 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
17329034 usd
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3430543 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3435269 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1463547 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3913207 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4348341 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13231398 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14374206 usd
CY2023Q1 us-gaap Assets
Assets
234530691 usd
CY2022Q4 us-gaap Assets
Assets
249821410 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
8356311 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
9177977 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
6068220 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
32100000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2294207 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 usd
CY2023Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
31231801 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
30744990 usd
CY2023Q1 us-gaap Liabilities
Liabilities
47950539 usd
CY2022Q4 us-gaap Liabilities
Liabilities
72022967 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
17332798 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
14126198 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3027738 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3027738 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
254558 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3010457 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3010457 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
219459 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
55690092 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
51688631 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
23568556 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
17011144 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
137125818 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
128994758 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
169247354 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
163672245 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
234530691 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
249821410 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33990503 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42256386 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
16362908 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18646894 usd
CY2023Q1 dhil Deferred Compensation Expense Benefit
DeferredCompensationExpenseBenefit
744511 usd
CY2022Q1 dhil Deferred Compensation Expense Benefit
DeferredCompensationExpenseBenefit
-1178556 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3506070 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3185971 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1652503 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1711160 usd
CY2023Q1 dhil Mutual Fund Administration
MutualFundAdministration
782944 usd
CY2022Q1 dhil Mutual Fund Administration
MutualFundAdministration
817878 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
23048936 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
23183347 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10941567 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
19073039 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
8082738 usd
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-7592257 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8082738 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7592257 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19024305 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11480782 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4921258 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3205766 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
14103047 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8275016 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1395495 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-854936 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12707552 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9129952 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.20
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.87
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.20
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.87
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3025094 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3185930 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3025094 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3185930 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
163672245 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14126198 usd
CY2023Q1 dhil Amortization Of Restricted Stock Grants
AmortizationOfRestrictedStockGrants
2843574 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7843 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
323070 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1132507 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4597931 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4576492 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12707552 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1395495 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
169247354 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17332798 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
184422902 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17756336 usd
CY2022Q1 dhil Amortization Of Restricted Stock Grants
AmortizationOfRestrictedStockGrants
2248679 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
487870 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
487870 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19249 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
437346 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9317661 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4818318 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9129952 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-854936 usd
CY2022Q1 dhil Subscription From Redemption Distribution To Noncontrolling Interest
SubscriptionFromRedemptionDistributionToNoncontrollingInterest
3837120 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
182610019 usd
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
20738520 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
14103047 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8275016 usd
CY2023Q1 us-gaap Depreciation
Depreciation
327961 usd
CY2022Q1 us-gaap Depreciation
Depreciation
362902 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2899872 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2333530 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1506623 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
689625 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3757754 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4081315 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1142808 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
875549 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
6929916 usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-7998535 usd
CY2023Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
1306643 usd
CY2022Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
5129789 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-26031780 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-27346796 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
486811 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-3379595 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
723698 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-691886 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13780407 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13678170 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13876 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22913 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5293030 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1684026 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4420337 usd
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3541113 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-886569 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1834174 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1132507 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
4576492 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
4818318 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
1811105 usd
CY2022Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
3837120 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4570126 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9317661 usd
CY2023Q1 dhil Proceeds Received Under Employee Stock Purchase Plan
ProceedsReceivedUnderEmployeeStockPurchasePlan
274617 usd
CY2022Q1 dhil Proceeds Received Under Employee Stock Purchase Plan
ProceedsReceivedUnderEmployeeStockPurchasePlan
371744 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8193403 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9927115 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22860379 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21771111 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63195302 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80550393 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40334923 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58779282 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
20696 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
487870 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements as well as the reported amounts of revenue and expense during the reporting period. Estimates have been prepared based on the most current and best available information, but actual results could differ materially from those estimates.</span></div>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts and disclosures may have been reclassified to conform to the current period’s financial presentation.</span></div>
CY2023Q1 us-gaap Investments
Investments
154784963 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3185930 shares
CY2023Q1 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1700000 usd
CY2023Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
38600000 usd
CY2022Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
2800000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
60400000 usd
CY2023Q1 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
8900000 usd
CY2022Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
9300000 usd
CY2022Q4 us-gaap Investments
Investments
145675711 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33990503 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42256386 usd
CY2023Q1 dhil Rolling Client Investment Performance Period
RollingClientInvestmentPerformancePeriod
P5Y
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
25510684 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
24105808 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
819135 usd
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1443747 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
5808171 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-9750856 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1509288 usd
CY2022Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
767885 usd
CY2023Q1 dhil Investment Income Other Incomeloss
InvestmentIncomeOtherIncomeloss
-53856 usd
CY2022Q1 dhil Investment Income Other Incomeloss
InvestmentIncomeOtherIncomeloss
-53033 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
8082738 usd
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-7592257 usd
CY2023Q1 dhil Equity Method Investment Deferred Compensation Plan Investments
EquityMethodInvestmentDeferredCompensationPlanInvestments
4800000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1248358 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
25510684 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
660571 usd
CY2023Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
38627607 usd
CY2023Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
23600000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
487870 usd
CY2023Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
2.500
CY2023Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.060
CY2023Q1 dhil Deferred Compensation Arrangement Fully Vested Employee Elected Deferral Period Minimum
DeferredCompensationArrangementFullyVestedEmployeeElectedDeferralPeriodMinimum
P5Y
CY2023Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
31200000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
30700000 usd
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.279
CY2023Q1 dhil Lessee Leasing Agreements Operating Leases Areaunder Lease
LesseeLeasingAgreementsOperatingLeasesAreaunderLease
37829 sqft
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1000000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1200000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
206077 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
204953 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
468134 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
624179 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
156045 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.046
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.015
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.013
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.006
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.009
CY2023Q1 dhil Effective Income Tax Rate Reconciliation Not Including Non Controlling Interest Percent
EffectiveIncomeTaxRateReconciliationNotIncludingNonControllingInterestPercent
0.279
CY2022Q1 dhil Effective Income Tax Rate Reconciliation Not Including Non Controlling Interest Percent
EffectiveIncomeTaxRateReconciliationNotIncludingNonControllingInterestPercent
0.260
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.020
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.019
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259
CY2023Q1 us-gaap Profit Loss
ProfitLoss
14103047 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8275016 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1395495 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-854936 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12707552 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9129952 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3025094 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3185930 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3025094 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.20
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.87
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.20
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.87

Files In Submission

Name View Source Status
dhil-20230331_def.xml Edgar Link unprocessable
0000909108-23-000036-index-headers.html Edgar Link pending
0000909108-23-000036-index.html Edgar Link pending
0000909108-23-000036.txt Edgar Link pending
0000909108-23-000036-xbrl.zip Edgar Link pending
dhil-20230331.htm Edgar Link pending
dhil-20230331.xsd Edgar Link pending
dhil-20230331_g1.jpg Edgar Link pending
ex-101x20230331brilliantam.htm Edgar Link pending
ex-311x20230331.htm Edgar Link pending
ex-312x20230331.htm Edgar Link pending
ex-321x20230331.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
dhil-20230331_cal.xml Edgar Link unprocessable
dhil-20230331_pre.xml Edgar Link unprocessable
dhil-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dhil-20230331_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending